Objective: This audit assessed the impact of individualised written recommendations and a computer message, on repeat prescriptions for calcium and vitamin D supplements, for patients on long term AEDs. Methods: 1041 adult patients with epilepsy were retrospectively followed from 2004, from the time of the introduction of the Quality and Outcomes Framework (QOF) and the publication of the National Institute of Clinical Evidence (NICE) guidelines for epilepsy, up until 2011. In 2009 a clinical notes review of 414 of the above patients, in Ellesmere Port and Neston (13 practices) was performed, suggesting supplementation, where appropriate, in a written report. A computer message was added to relevant prescriptions also recommending supplements, in the above practices plus all 26 practices in Chester and the surrounding area. The number of patients receiving repeat prescription for supplements in each area between 2004 and 2011 was analysed.
Results: There was a significant increase in the repeat prescriptions of supplements in 2010/11 after the interventions, the increase being most marked in Ellesmere Port and Neston where both written recommendations and computer message had occurred compared with the two areas with the computer message only. Conclusion: Quality audit with written recommendations, and a message added to the General Practice (GP) computer systems significantly increased the number of repeat prescriptions of calcium and vitamin D supplements in this group of patients. Practice Implications: Where clear guidelines are established, this study demonstrates that continuing education and counselling of GPs and use of computer messaging would result in improved compliance with such guidelines. In 2004 the Quality and Outcomes Framework (QOF) for patients with epilepsy was introduced in the UK. This facilitated annual review of adult patients with epilepsy in primary care, this carried a financial incentive. The data collected in such a review was limited to creating a register of patients, recording seizure frequency, recording patients who were 'convulsion' free and a 'review of AED medication' in the proceeding 15 months. 9 Since the introduction of QOF the rate of the reviews in the area under study was on average 95%. 10 We postulated that an audit intervention and computer message would increase the prescription of calcium and vitamin D supplementation in patients on long term AED therapy.
Methods
In 2009 a comprehensive notes review of all patients with active epilepsy, aged 16 years or older, was undertaken by one of the authors (IM), a GP with a Special Interest in epilepsy (GPwSIe), in 13 GP practices in Ellesmere Port and Neston. This included identification of patients prescribed an AED associated with potential deleterious effect on bone metabolism, with a written recommendation that appropriate supplementation be prescribed, in a summary report, to the local GPs. Seventy one percent of these patients had been prescribed an AED effecting bone for 10 years or longer. Similar notes reviews had taken place in Chester (13 practices) and the Rural area surrounding Chester (13 practices) in 2002-2004, where no recommendation had been made concerning calcium and vitamin D supplementation. 11, 12 At the same time the following message using Scriptswitch software was added when a prescription was issued: 'Calcium & Vitamin D supplementation should be considered for patients who receive valproate/carbamazepine/phenytoin/primidone for long-term treatment (DSU Apr 09)'. This occurred in all three areas.
The GP records of 1041 patients aged 16 or over with a diagnosis of epilepsy receiving a continual repeat prescription for an AED were identified using Graphnet software and followed from 2004, when the QOF for epilepsy was introduced for GPs and the NICE epilepsy guidelines were published, through to 2011. The number of these patients receiving repeat prescriptions for calcium and vitamin D supplements were also identified.
Approval for the study was obtained from the South Cheshire Local Research Ethics Committee.
Categorical variables were analysed using x 2 test, using SPSS 13.0 (SPSS Inc., Chicago, IL, USA). A p value of <0.05 was considered to be statistically significant.
Results
There were small numbers of supplement prescriptions from 2004 to 2009 with no significant year on year change. A significant rise in the number of supplementation prescriptions occurred in 2010/11 the year after the provision of the written recommendations and introduction of the computer message (Table 1) .
A statistically significant increase in calcium and vitamin D prescriptions occurred in Ellesmere Port and Neston (written recommendation and computer message) compared with the City and Rural (p = 0.0009) practices (computer message alone) in 2010/11, with no difference in the previous period 2008/09.
Discussion
This study demonstrates a significant increase in the prescription of calcium and vitamin D supplements following written recommendations for local GPs, in addition to the introduction of a computer message. The use of computer messaging alone resulted in a less marked but still statistically significant increase.
There is evidence that a significant proportion of the population of the UK are vitamin D deficient to begin with. 13 The DSU recommends that vitamin D supplementation should be considered for patients taking four named AEDs, whilst NICE similarly recommends the investigation of bone health, although no specific recommendation regarding supplementation where appropriate is made. The literature studying the AEDs and their effect on bone health suggest a consensus recommending supplementation with vitamin D and Calcium. In the only randomised controlled trial (RCT) for adults on long term AED therapy patients were prescribed either low dose (400 IU/day) or high dose (4000 IU/day) vitamin D. Baseline Bone Mineral Density (BMD) was lower in the adults compared with controls. After one year BMD scores were significantly higher in those receiving the higher dose, but not in the lower dose group. 15 The standard supplementation currently prescribed in the UK contains 800 IU/day (2 Adcal D3, Calceos etc.) suggesting a higher formulation is needed. New preparations of vitamin D capsules of varying strengths have recently become available in the UK, but were not available at the time of the study.
In this study 71% of patients have been on an AED effecting bone health for 10 years or more. If this figure was representative of the general UK epilepsy population then this would represent a significant health need which is currently not being met. We did not identify any potential confounding factors such an alternative educational programmes in the areas, during the period under study, to account in the change in prescription practices.
The recommendation regarding supplements and investigation of bone health could easily be added to the QOF targets for epilepsy, to remind GPs to consider the prescription of supplements, as the contraception and pre-conception indicators were added in 2011.
Ideally long term follow up of the identified cohort in whom the interventions resulted in supplementation, should be undertaken, to determine if this results in improved health care (increased BMD and subsequent reduced fracture rates) compared with people on long-term AEDs without supplementation.
